Inherited IL-12 unresponsiveness contributes to the high LPS resistance of the Lpsd C57BL/10ScCr mouse

被引:44
作者
Merlin, T [1 ]
Sing, A [1 ]
Nielsen, PJ [1 ]
Galanos, C [1 ]
Freudenberg, MA [1 ]
机构
[1] Max Planck Inst Immunbiol, D-79108 Freiburg, Germany
关键词
D O I
10.4049/jimmunol.166.1.566
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Lps(d) mouse strains are characterized by the presence of a defective Lps/tlr4 gene that make them refractory to the biological activity of LPS, One of the mouse strains commonly used to study LPS defects is the C57BL/10ScCr (Cr) strain. However, unlike other Lpsd strains, the Cr strain also has a heavily impaired IFN-gamma response to micro-organisms. As a consequence, unlike other Lpsd mouse strains, they do not acquire a partial LPS susceptibility when treated with sensitizing bacteria. Because IL-12 is important for the microbial induction of IFN-gamma, we investigated whether the production or function of IL-12 might be defective in Cr mice, IL-12 mRNA (p35 and p40) was present in the spleen of untreated Cr mice, IL-12p40 mRNA was inducible in mice injected with live or killed Salmonella typhimurium, and IL-12 (p70) was inducible in macrophages by bacteria. Thus, Cr mice exhibit normal IL-12 responses. In functional tests, splenocytes of untreated or of S. typhimurium-infected mice failed to produce IFN-gamma when stimulated with murine rIL-12 or with a combination of IL-12 and murine rIL-18 or Con A. Furthermore, Cr mice were identical with IL-12p35/p40 and IL-12 receptor beta (1) knockout mice in their impaired in vivo and in vitro IFN-gamma responses to bacteria. Thus, Cr mire tarry a second genetic defect unrelated to the Lps/tlr4 mutation that underlies the IL-12 unresponsiveness and contributes to the LPS resistance and impaired innate immune response in this strain.
引用
收藏
页码:566 / 573
页数:8
相关论文
共 58 条
  • [1] ABERNATHY RS, 1958, J IMMUNOL, V81, P271
  • [2] ADORINI L, 1997, CHEM IMMUNOL, V68, P1
  • [3] AGGARWAL BB, 1985, J BIOL CHEM, V260, P2345
  • [4] BELLONE G, 1995, J IMMUNOL, V155, P1066
  • [5] Bohn E, 1998, J IMMUNOL, V160, P299
  • [6] INTERLEUKIN (IL)-15 IS A NOVEL CYTOKINE THAT ACTIVATES HUMAN NATURAL-KILLER-CELLS VIA COMPONENTS OF THE IL-2 RECEPTOR
    CARSON, WE
    GIRI, JG
    LINDEMANN, MJ
    LINETT, ML
    AHDIEH, M
    PAXTON, R
    ANDERSON, D
    EISENMANN, J
    GRABSTEIN, K
    CALIGIURI, MA
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (04) : 1395 - 1403
  • [7] SINGLE-STEP METHOD OF RNA ISOLATION BY ACID GUANIDINIUM THIOCYANATE PHENOL CHLOROFORM EXTRACTION
    CHOMCZYNSKI, P
    SACCHI, N
    [J]. ANALYTICAL BIOCHEMISTRY, 1987, 162 (01) : 156 - 159
  • [8] GENETIC BASIS FOR UNRESPONSIVENESS TO LIPOPOLYSACCHARIDE IN C57BL-10CR MICE
    COUTINHO, A
    MEO, T
    [J]. IMMUNOGENETICS, 1978, 7 (01) : 17 - 24
  • [9] STIMULATORY AND INHIBITORY EFFECTS OF INTERLEUKIN (IL)-4 AND IL-13 ON THE PRODUCTION OF CYTOKINES BY HUMAN PERIPHERAL-BLOOD MONONUCLEAR-CELLS - PRIMING FOR IL-12 AND TUMOR-NECROSIS-FACTOR-ALPHA PRODUCTION
    DANDREA, A
    MA, XJ
    ASTEAMEZAGA, M
    PAGANIN, C
    TRINCHIERI, G
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (02) : 537 - 546
  • [10] PRODUCTION OF NATURAL-KILLER-CELL STIMULATORY FACTOR (INTERLEUKIN-12) BY PERIPHERAL-BLOOD MONONUCLEAR-CELLS
    DANDREA, A
    RENGARAJU, M
    VALIANTE, NM
    CHEHIMI, J
    KUBIN, M
    ASTE, M
    CHAN, SH
    KOBAYASHI, M
    YOUNG, D
    NICKBARG, E
    CHIZZONITE, R
    WOLF, SF
    TRINCHIERI, G
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (05) : 1387 - 1398